| Online-Ressource |
Verfasst von: | Rohde, David [VerfasserIn]  |
| Brinks, Henriette [VerfasserIn]  |
| Ritterhoff, Julia [VerfasserIn]  |
| Qui, Gang [VerfasserIn]  |
| Ren, Shumei [VerfasserIn]  |
| Most, Patrick [VerfasserIn]  |
Titel: | S100A1 gene therapy for heart failure |
Titelzusatz: | A novel strategy on the verge of clinical trials |
Verf.angabe: | David Rohde, Henriette Brinks, Julia Ritterhoff, Gang Qui, Shumei Ren, Patrick Most |
Jahr: | 2011 |
Umfang: | 8 S. |
Fussnoten: | Available online 20 August 2010 ; Gesehen am 19.09.2022 |
Titel Quelle: | Enthalten in: Journal of molecular and cellular cardiology |
Ort Quelle: | New York, NY [u.a.] : Elsevier, 1970 |
Jahr Quelle: | 2011 |
Band/Heft Quelle: | 50(2011), 5, Seite 777-784 |
ISSN Quelle: | 1095-8584 |
Abstract: | Representing the common endpoint of various cardiovascular disorders, heart failure (HF) shows a dramatically growing prevalence. As currently available therapeutic strategies are not capable of terminating the progress of the disease, HF is still associated with a poor clinical prognosis. Among the underlying molecular mechanisms, the loss of cardiomyocyte Ca2+ cycling integrity plays a key role in the pathophysiological development and progression of the disease. The cardiomyocyte EF-hand Ca2+ sensor protein S100A1 emerged as a regulator both of sarcoplasmic reticulum (SR), sarcomere and mitochondrial function implicating a significant role in cardiac physiology and dysfunction. In this review, we aim to recapitulate the translation of S100A1-based investigation from first clinical observations over basic research experiments back to a near-clinical setting on the verge of clinical trials today. We also address needs for further developments towards “second-generation” gene therapy and discuss the therapeutic potential of S100A1 gene therapy for HF as a promising novel strategy for future cardiologists. This article is part of a Special Section entitled “Special Section: Cardiovascular Gene Therapy”. |
DOI: | doi:10.1016/j.yjmcc.2010.08.012 |
URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
Volltext ; Verlag: https://doi.org/10.1016/j.yjmcc.2010.08.012 |
| Volltext: https://www.sciencedirect.com/science/article/pii/S0022282810002993 |
| DOI: https://doi.org/10.1016/j.yjmcc.2010.08.012 |
Datenträger: | Online-Ressource |
Sprache: | eng |
Sach-SW: | Calcium |
| Gene therapy |
| Heart failure |
| Mitochondria |
| Myofilaments |
| Reticulum |
| S100A1 |
| Sarcoplasmic |
K10plus-PPN: | 1816934895 |
Verknüpfungen: | → Zeitschrift |
S100A1 gene therapy for heart failure / Rohde, David [VerfasserIn]; 2011 (Online-Ressource)